Log In
Print this Print this

DNA Damage Repair Deficient (DDRD) assay

  Manage Alerts
Collapse Summary General Information
Company Almac Group Ltd.
DescriptionAssay that uses a 44 gene classifier to prospectively identify patients with a deficiency in DNA damage repair from tumor samples
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPreclinical
Standard IndicationCancer, Diagnostic
Indication DetailsPredict response to breast cancer chemotherapy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today